$3.08 Billion is the total value of PURA VIDA INVESTMENTS, LLC's 226 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| OCX | ONCOCYTE CORP | $18,214,000 | -31.3% | 12,223,953 | 0.0% | 0.59% | -38.5% | |
| CYTOKINETICS INCnote 4.000%11/1 | $9,149,000 | -17.9% | 25,000 | 0.0% | 0.30% | -26.5% | ||
| DA32 LIFE SCNCE TEC ACQSTN C | $1,601,000 | -1.0% | 164,834 | 0.0% | 0.05% | -11.9% | ||
| MDVL | MEDAVAIL HOLDINGS INC | $693,000 | -30.7% | 714,120 | 0.0% | 0.02% | -38.9% | |
| GOSSAMER BIO INCnote 5.000% 6/0 | $402,000 | -18.0% | 5,000 | 0.0% | 0.01% | -27.8% | ||
| SOMALOGIC INC*w exp 08/31/202 | $413,000 | -39.5% | 204,401 | 0.0% | 0.01% | -48.0% | ||
| ROIVANT SCIENCES LTD*w exp 09/30/202 | $176,000 | -57.0% | 199,648 | 0.0% | 0.01% | -60.0% | ||
| TCACU | TUATARA CAPITAL ACQUISITN COunit 99/99/9999 | $198,000 | -1.5% | 20,000 | 0.0% | 0.01% | -14.3% | |
| MAPSW | WM TECHNOLOGY INC*w exp 06/16/202 | $110,000 | +64.2% | 50,000 | 0.0% | 0.00% | +100.0% | |
| TALKW | TALKSPACE INC*w exp 06/21/202 | $103,000 | +4.0% | 427,194 | 0.0% | 0.00% | -25.0% | |
| EFFECTOR THERAPEUTICS INC*w exp 12/31/202 | $35,000 | -60.2% | 100,541 | 0.0% | 0.00% | -66.7% | ||
| RENOVACOR INC*w exp 99/99/999 | $41,000 | -52.3% | 150,632 | 0.0% | 0.00% | -66.7% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-16
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ICU MED INC | 26 | Q2 2023 | 4.2% |
| NANOSTRING TECHNOLOGIES INC | 26 | Q2 2023 | 3.3% |
| VIEWRAY INC | 25 | Q2 2023 | 3.2% |
| LIVANOVA PLC | 23 | Q3 2023 | 3.8% |
| ALEXION PHARMACEUTICALS INC | 23 | Q1 2021 | 4.3% |
| INSPIRE MED SYS INC | 22 | Q3 2023 | 3.7% |
| BOSTON SCIENTIFIC CORP | 22 | Q3 2022 | 4.8% |
| INVACARE CORP | 22 | Q3 2021 | 2.8% |
| ESTABLISHMENT LABS HLDGS INC | 21 | Q3 2023 | 5.0% |
| INTERSECT ENT INC | 21 | Q2 2021 | 2.6% |
View PURA VIDA INVESTMENTS, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Stryve Foods Holdings, LLC | April 19, 2023 | 1,470,649 | 5.6% |
| ICAD INC | March 15, 2023 | 1,277,214 | 5.0% |
| ESTABLISHMENT LABS HOLDINGS INC. | February 14, 2023 | 1,002,767 | 4.1% |
| Pulmonx Corp | February 14, 2023 | 1,216,258 | 3.2% |
| Quotient LtdSold out | February 14, 2023 | 0 | 0.0% |
| Universe Pharmaceuticals INCSold out | February 14, 2023 | 0 | 0.0% |
| MedMen Enterprises, Inc. | April 29, 2022 | 139,755,072 | 21.4% |
| INVACARE CORPSold out | February 14, 2022 | 0 | 0.0% |
| MedAvail Holdings, Inc. | February 14, 2022 | 714,120 | 2.2% |
| TELA Bio, Inc. | February 14, 2022 | 564,120 | 3.9% |
View PURA VIDA INVESTMENTS, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2024-02-13 |
| SC 13D/A | 2023-12-29 |
View PURA VIDA INVESTMENTS, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.